In Q1 16, revenues declined 6.1% to €13.87bn. The revenue decline was mainly driven by the revised revenue recognition terms of a contract with the National Health Service in the UK of around €465m. In addition, negative currency effects contributed €402m to lower revenues. Excluding these two effects revenues would have remained flat. EBIT however improved 21.1% to €872m and the EBIT margin increased from 4.9% to 6.3%. Net profit jumped 29.1% to €639m.
